1,451 followers
RT @FBDDworld: Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle. https://t.co/eotpqt5OL5
RT @FBDDworld: Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle. https://t.co/eotpqt5OL5
Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle. https://t.co/eotpqt5OL5
RT @EuropePMC: New from #ERC_Research https://t.co/gZyS96VTPu Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclini…
New from #ERC_Research https://t.co/gZyS96VTPu Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle